De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis.
Caforio
A L
AL
Department of Cardiology, University of Padova Medical School, Padova, Italy. alida.caforio@unipd.it
Gambino
A
A
Piaserico
S
S
Tona
F
F
Belloni Fortina
A
A
Feltrin
G
G
Angelini
A
A
Thiene
G
G
Peserico
A
A
Casarotto
D
D
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009206:Myocardium / Q000473:pathology; D009369:Neoplasms / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone